{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:04:46Z","timestamp":1789178686514,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jvs.2024.05.005","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T02:06:04Z","timestamp":1715133964000},"page":"1149-1158.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Polyvascular disease is common in patients undergoing carotid endarterectomy and lower extremity bypass and is associated with worse outcomes"],"prefix":"10.1016","volume":"80","author":[{"given":"Kris M.","family":"Boelitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3401-1974","authenticated-orcid":false,"given":"Alexandra","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica P.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Siracuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alik","family":"Farber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Hamburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Eberhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Schanzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8829-2831","authenticated-orcid":false,"given":"Douglas W.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2024.05.005_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.007385","article-title":"Polyvascular disease: reappraisal of the current clinical landscape","volume":"12","author":"Gutierrez","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2024.05.005_bib2","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jama.2010.1322","article-title":"Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis","volume":"304","author":"Bhatt","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2024.05.005_bib3","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/eurheartj\/ehp099","article-title":"Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes","volume":"30","author":"Bhatt","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2024.05.005_bib4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.amjcard.2009.10.048","article-title":"Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)","volume":"105","author":"Krempf","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvs.2024.05.005_bib5","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1093\/eurheartj\/ehx102","article-title":"Identification of vascular patients at very high risk for recurrent cardiovascular events: validation of the current ACC\/AHA very high risk criteria","volume":"38","author":"van den Berg","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2024.05.005_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2020.11.001","article-title":"Polyvascular disease: a narrative review of current evidence and a consideration of the role of antithrombotic therapy","volume":"315","author":"Weissler","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jvs.2024.05.005_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.5239","article-title":"Polyvascular disease and risk of major adverse cardiovascular events in peripheral artery disease: a secondary analysis of the EUCLID trial","volume":"1","author":"Gutierrez","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jvs.2024.05.005_bib8","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/CIRCULATIONAHA.118.033580","article-title":"Combination antiplatelet and oral anticoagulant therapy in patients with coronary and peripheral artery disease","volume":"139","author":"Gurbel","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2024.05.005_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.120.046048","article-title":"The COMPASS trial: net clinical benefit of low-dose rivaroxaban plus aspirin as compared with aspirin in patients with chronic vascular disease","volume":"142","author":"Steffel","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2024.05.005_bib10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ejvs.2009.05.006","article-title":"The prevalence of polyvascular disease in patients referred for peripheral arterial disease","volume":"38","author":"Vidakovic","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2024.05.005_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1611688","article-title":"Ticagrelor versus clopidogrel in symptomatic peripheral artery disease","volume":"376","author":"Hiatt","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2024.05.005_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.avsg.2023.10.004","article-title":"Polyvascular disease influences long-term cardiovascular morbidity in carotid endarterectomy","volume":"102","author":"Thierstein","year":"2023","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2024.05.005_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/2047487313519344","article-title":"Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study","volume":"22","author":"Subherwal","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jvs.2024.05.005_bib14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1177\/1358863X18796936","article-title":"Polyvascular disease and risk: when two is not better than one","volume":"23","author":"Bonaca","year":"2018","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvs.2024.05.005_bib15","first-page":"21","article-title":"Rivaroxaban and aspirin in patients with symptomatic lower extremity peripheral artery disease: a subanalysis of the COMPASS randomized clinical trial","volume":"6","author":"Kaplovitch","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jvs.2024.05.005_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1253\/circj.CJ-12-0535","article-title":"Prevalence and clinical outcome of polyvascular atherosclerotic disease in patients undergoing coronary intervention","volume":"77","author":"Miura","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.jvs.2024.05.005_bib17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ancard.2020.07.002","article-title":"Clinical characteristics and outcomes of COMPASS eligible patients in France. An analysis from the REACH Registry","volume":"69","author":"Darmon","year":"2020","journal-title":"Ann Cardiol Angeiol"},{"key":"10.1016\/j.jvs.2024.05.005_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jvs.2018.05.229","article-title":"The impact of chronic kidney disease on lower extremity bypass outcomes in patients with critical limb ischemia","volume":"69","author":"Ambur","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.05.005_bib19","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ejvs.2021.01.013","article-title":"Impact of chronic kidney disease under nephrology care on outcomes of carotid endarterectomy","volume":"61","author":"Jeong","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2024.05.005_bib20","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jvs.2016.04.038","article-title":"Perioperative and long-term impact of chronic kidney disease on carotid artery interventions","volume":"64","author":"Klarin","year":"2016","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.05.005_bib21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/1708538117691430","article-title":"A\u00a0contemporary evaluation of carotid endarterectomy outcomes in patients with chronic kidney disease in the United States","volume":"25","author":"Patel","year":"2017","journal-title":"Vascular"},{"key":"10.1016\/j.jvs.2024.05.005_bib22","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.jacc.2016.03.524","article-title":"Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease","volume":"67","author":"Bonaca","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2024.05.005_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2024.05.005_bib24","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/ehjcvp\/pvac023","article-title":"Long-term treatment with the combination of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: outcomes during the open label extension of the COMPASS trial","volume":"8","author":"Eikelboom","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jvs.2024.05.005_bib25","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2024.05.005_bib26","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2024.05.005_bib27","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jvs.2022.11.062","article-title":"Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits","volume":"77","author":"Govsyeyev","year":"2022","journal-title":"J\u00a0Vasc Surg"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521424011042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521424011042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T19:03:12Z","timestamp":1729623792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521424011042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0741521424011042"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2024.05.005","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyvascular disease is common in patients undergoing carotid endarterectomy and lower extremity bypass and is associated with worse outcomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2024.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}